Author

N. Lypova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

B. F. Clem· 1 shared J. A. Chesney· 1 shared J. Feng· 1 shared S. M. Dougherty· 1 shared X. Li· 1 shared X. Yin· 1 shared X. ZhangiD· 1 shared Y. Imbert-Fernandez· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. F. Clem

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Role of 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 in Maintaining Redox Homeostasis and DNA Repair in Non-Small Cell Lung Cancers Under EGFR-Targeting Therapy

N. Lypova, S. M. Dougherty, B. F. Clem, J. Feng, X. Yin, X. Zhang, X. Li, J. A. Chesney, Y. Imbert-Fernandez

This study shows that inhibiting PFKFB3 enhances the effectiveness of EGFR-TKIs by disrupting metabolic adaptations and DNA repair in drug-tolerant lung cancer cells.

bioRxiv · Mar 25, 2024 · PreprintCancer Biology